Mayuri Iyer
Mayuri Iyer has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Chayan Munshi
Ethophilia Research Foundation, Santiniketan 731235, India
1 shared publication - Farhan Jamil
Ethophilia Research Foundation, India
1 shared publication - Ishika Pal
Ethophilia Research Foundation, India
1 shared publication - Litika Vermani
Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden
1 shared publication - Monalisa Bora Deka
The Assam Royal Global University, Guwahati, India
1 shared publication - Poulome Mukherjee
Cachar Cancer Hospital and Research Centre
1 shared publication
Latest Publications
- Open Access
- 10 November 2025
- Published by Springer Nature in Research Square
PUM1 and RPN1 are Optimum Reference Genes for Differential Gene Expression Analysis of Cancer Stem Cell and Epithelial-to-Mesenchymal Transition Markers in Breast Cancer
Background: Reliability of differential gene expression analysis in cancer studies depends on the selection of normalising reference genes. The current study aimed to identify and validate suitable reference genes for the normalization of quantitative real-time polymerase chain reaction (qPCR)-based differential gene expression analysis of cancer stem cells (CSC) and epithelial-to-mesenchymal transition (EMT) markers in breast cancer tissue. Methodology: The expression stability of six candidate reference genes— PUM1, RPN1, GUSB, PMM1, GAPDH, and B2M —across 18 breast cancer specimens was assessed using qPCR method. Gene stability was analysed using RefFinder algorithm. Further, the suitability of the optimum reference genes was assessed using qPCR-based differential gene expression analysis of CSC and EMT markers, namely ALDH1 , VIM , TWIST , and CDH1 , in a cohort of breast cancer tissues constituting the four intrinsic molecular subgroups– Luminal A, Luminal B, Triple Negative Breast Cancer (TNBC), and HER 2-Enriched. Results: The geometric mean of C q values for PUM1, RPN1, GUSB, PMM, B2M, and GAPDH were found 19.95, 18.26, 21.12, 22.10, 14.64, and 16.0, respectively. ReFfinder provided a comprehensive assessment of gene stability, ranking the candidate reference genes in the following order of decreasing stability: PUM1 (1.0), RPN1 (1.86), GUSB (3.41), PMM (4.0), B2M (4.56), and GAPDH (5.23). PUM1 and RPN1 were observed as the most stably expressed reference genes whereas GAPDH was most unstably expressed across all the breast cancer tissues. Using PUM1 and RPN1 as reference genes, the following gene expression patterns were observed: ALDH1 showed the lowest expression in Luminal B; TWIST and VIM expressions peaked in HER 2-Enriched subtype, with VIM being expressed the lowest in Luminal B; CDH1 expression was lowest in HER 2-Enriched and highest in Luminal B. Conclusion: In our cohort PUM1 and RPN1 reference genes were found to be most stable and were suitable for the normalization of qPCR-based gene expression of CSC and EMT markers. However, these findings need to be validated on a larger cohort.
- 10 November 2025
- Published by Springer Nature in Research Square
Open AccessPUM1 and RPN1 are Optimum Reference Genes for Differential Gene Expression Analysis of Cancer Stem Cell and Epithelial-to-Mesenchymal Transition Markers in Breast Cancer
Background: Reliability of differential gene expression analysis in cancer studies depends on the selection of normalising reference genes. The current study aimed to identify and validate suitable reference genes for the normalization of quantitative real-time polymerase chain reaction (qPCR)-based differential gene expression analysis of cancer stem cells (CSC) and epithelial-to-mesenchymal transition (EMT) markers in breast cancer tissue. Methodology: The expression stability of six candidate reference genes— PUM1, RPN1, GUSB, PMM1, GAPDH, and B2M —across 18 breast cancer specimens was assessed using qPCR method. Gene stability was analysed using RefFinder algorithm. Further, the suitability of the optimum reference genes was assessed using qPCR-based differential gene expression analysis of CSC and EMT markers, namely ALDH1 , VIM , TWIST , and CDH1 , in a cohort of breast cancer tissues constituting the four intrinsic molecular subgroups– Luminal A, Luminal B, Triple Negative Breast Cancer (TNBC), and HER 2-Enriched. Results: The geometric mean of C q values for PUM1, RPN1, GUSB, PMM, B2M, and GAPDH were found 19.95, 18.26, 21.12, 22.10, 14.64, and 16.0, respectively. ReFfinder provided a comprehensive assessment of gene stability, ranking the candidate reference genes in the following order of decreasing stability: PUM1 (1.0), RPN1 (1.86), GUSB (3.41), PMM (4.0), B2M (4.56), and GAPDH (5.23). PUM1 and RPN1 were observed as the most stably expressed reference genes whereas GAPDH was most unstably expressed across all the breast cancer tissues. Using PUM1 and RPN1 as reference genes, the following gene expression patterns were observed: ALDH1 showed the lowest expression in Luminal B; TWIST and VIM expressions peaked in HER 2-Enriched subtype, with VIM being expressed the lowest in Luminal B; CDH1 expression was lowest in HER 2-Enriched and highest in Luminal B. Conclusion: In our cohort PUM1 and RPN1 reference genes were found to be most stable and were suitable for the normalization of qPCR-based gene expression of CSC and EMT markers. However, these findings need to be validated on a larger cohort.
- Open Access
- 26 May 2025
- Published by IntechOpen
The Effective Stress Response Role of p53 in Inducing Ferroptotic Cell Death
Ferroptosis, an iron-dependent regulated cell death (RCD) or programmed cell death (PCD), effectively occurs due to iron overload in the cells, thus depleting the glutathione-dependent antioxidant system, and eventually causes cellular lipid peroxidation. P53 is a well-established molecule involved in cellular stress response leading to the initiation of RCD/PCD. It is known to be involved in the onset of ferroptotic cell death through distinct diverse molecular pathways. Through this chapter, we want to elucidate a possible pathway of increased iron intake in the cell and a comprehensive analysis of the possible mechanisms on how p53-induced ferroptotic cell death occurs due to the disbalance in cellular iron homeostasis.
- 26 May 2025
- Published by IntechOpen
Open AccessThe Effective Stress Response Role of p53 in Inducing Ferroptotic Cell Death
Ferroptosis, an iron-dependent regulated cell death (RCD) or programmed cell death (PCD), effectively occurs due to iron overload in the cells, thus depleting the glutathione-dependent antioxidant system, and eventually causes cellular lipid peroxidation. P53 is a well-established molecule involved in cellular stress response leading to the initiation of RCD/PCD. It is known to be involved in the onset of ferroptotic cell death through distinct diverse molecular pathways. Through this chapter, we want to elucidate a possible pathway of increased iron intake in the cell and a comprehensive analysis of the possible mechanisms on how p53-induced ferroptotic cell death occurs due to the disbalance in cellular iron homeostasis.